June 5, 2025 03:09 PM EDT
China
Pharma

Biotech ranks as Chi­na’s best shot to sur­pass US in emerg­ing tech, re­port finds

Jared Whitlock

Features Editor

Among five tech sec­tors, Chi­na has the most im­me­di­ate op­por­tu­ni­ty to over­take the US in biotech­nol­o­gy.

That’s ac­cord­ing to a

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

MIT sci­en­tists’ AI mod­el one-ups Al­phaFold 3, takes on ‘fun­da­men­tal is­sue’ in drug R&D

Up­dat­ed: Oma­da Health rose 21% in its pub­lic mar­ket de­but

Is there still hope for Sum­mit's can­cer drug buried in the da­ta?

EMA con­sid­ers se­ri­ous eye con­di­tion a ‘very rare’ side ef­fect of semaglu­tide 

GSK taps Sanofi vet to lead vac­cine R&D; Bris­tol My­ers names head of cor­po­rate af­fairs

sponsored

Cy­ti­va and Eu­rek­aBio form strate­gic part­ner­ship to ad­vance lentivi­ral vec­tor man­u­fac­tur­ing for cell and gene ther­a­py ...

A service from the Financial Times